Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$884M |
| 2 |
Tesla
TSLA
|
+$641M |
| 3 |
Visa
V
|
+$520M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$907M |
| 4 |
Microsoft
MSFT
|
+$832M |
| 5 |
Privia Health
PRVA
|
+$655M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.24% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 8.04% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Sana Biotechnology
SANA
$963M
| $5.12M | ﹤0.01% |
859,249
-116,845
| -12% | -$673K |
|
3052
iShares Residential and Multisector Real Estate ETF
REZ
$874M
| $5.12M | ﹤0.01% |
69,871
-21,381
| -23% | -$1.53M |
|
3053
Enanta Pharmaceuticals
ENTA
$391M
| $5.12M | ﹤0.01% |
239,069
+8,979
| +4% | +$265K |
|
3054
Sutro Biopharma
STRO
$422M
| $5.11M | ﹤0.01% |
109,887
-40,174
| -27% | -$2M |
|
3055
Dine Brands
DIN
$454M
| $5.1M | ﹤0.01% |
87,843
-4,935
| -5% | -$314K |
|
3056
NextDecade
NEXT
$1.7B
| $5.08M | ﹤0.01% |
618,444
+127,784
| +26% | +$784K |
|
3057
Universal Corp
UVV
$1.3B
| $5.05M | ﹤0.01% |
101,073
+46,466
| +85% | +$2.44M |
|
3058
Alamo Group
ALG
$2.06B
| $5.05M | ﹤0.01% |
27,433
-1,375
| -5% | -$245K |
|
3059
St. Joe Company
JOE
$3.7B
| $5.05M | ﹤0.01% |
104,367
-17,823
| -15% | -$777K |
|
3060
PUT
First Solar
FSLR
$25.4B
| $5.02M | ﹤0.01% |
26,400
-35,600
| -57% | -$7.05M |
|
3061
CALL
Amgen
AMGN
$223B
| $5.02M | ﹤0.01% |
22,600
-9,600
| -30% | -$2.23M |
|
|
VERV
3062
DELISTED
Verve Therapeutics
VERV
| $5.01M | ﹤0.01% |
267,078
+4,135
| +2% | +$68.9K |
|
3063
Compass
COMP
$9.76B
| $5M | ﹤0.01% |
1,428,428
+825,867
| +137% | +$2.71M |
|
|
3064
CALL
First Solar
FSLR
$25.4B
| $5M | ﹤0.01% |
26,300
-48,100
| -65% | -$9.53M |
|
3065
Popular Inc
BPOP
$11.3B
| $5M | ﹤0.01% |
82,600
-66,235
| -45% | -$3.9M |
|
3066
PUT
Wynn Resorts
WYNN
$11.2B
| $4.98M | ﹤0.01% |
47,200
+200
| +0.4% | +$21.4K |
|
3067
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
| $4.97M | ﹤0.01% |
50,000
| – | – |
|
3068
Harley-Davidson
HOG
$2.8B
| $4.97M | ﹤0.01% |
141,105
-409,778
| -74% | -$14.3M |
|
3069
uniQure
QURE
$3.01B
| $4.97M | ﹤0.01% |
433,424
+4,138
| +1% | +$78.4K |
|
3070
First Hawaiian
FHB
$3.42B
| $4.97M | ﹤0.01% |
275,747
-17,420
| -6% | -$320K |
|
3071
Green Dot
GDOT
$748M
| $4.96M | ﹤0.01% |
264,919
+116,740
| +79% | +$2.07M |
|
3072
Atlanta Braves Holdings Series B
BATRK
$3.1B
| $4.96M | ﹤0.01% |
125,207
-59,860
| -32% | -$2.25M |
|
3073
Immuneering
IMRX
$281M
| $4.96M | ﹤0.01% |
488,863
+462,652
| +1,765% | +$4.45M |
|
3074
Schwab US Large- Cap ETF
SCHX
$74.3B
| $4.96M | ﹤0.01% |
283,938
+173,580
| +157% | +$2.87M |
|
3075
Editas Medicine
EDIT
$427M
| $4.96M | ﹤0.01% |
602,184
-103,872
| -15% | -$905K |
|
Similar funds
Goldman Sachs's Q2 2023 Portfolio in Review
As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q2 2023 filing shows 443 new, 2,419 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
- Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
- Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
- Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
- Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
- Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
- Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.